← Back to home

Lymphoblastic lymphoma (precursor B-lymphoblastic lymphoma/leukaemia) refractory

Clinical trials for Lymphoblastic lymphoma (precursor B-lymphoblastic lymphoma/leukaemia) refractory explained in plain language.

Never miss a new study

Get alerted when new Lymphoblastic lymphoma (precursor B-lymphoblastic lymphoma/leukaemia) refractory trials appear

Sign up with your email to follow new studies for Lymphoblastic lymphoma (precursor B-lymphoblastic lymphoma/leukaemia) refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1

Promising drug cocktail targets tough childhood cancers

Disease control Not yet recruiting

This trial tests a combination of three drugs—capivasertib, venetoclax, and dexamethasone—in children and young adults with relapsed or refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL). The study has two phases: first, to find the safest dose, and sec…

Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY

Phase 1/2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control

Last updated Jun 26, 2026 17:34 UTC

Lymphoblastic lymphoma (precursor B-lymphoblastic lymphoma/leukaemia) refractory

Get alerted when new Lymphoblastic lymphoma (precursor B-lymphoblastic lymphoma/leukaemia) refractory trials appear

Promising drug cocktail targets tough childhood cancers